Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

by Kihyuck Kwak, Rosie Jiang, Joshua W Wang, Subhashini Jagu, Reinhard Kirnbauer, Richard B S Roden
Published 2014-01-01

Immunologic Control of Mus musculus Papillomavirus Type 1.

by Joshua W Wang, Rosie Jiang, Shiwen Peng, Yung-Nien Chang, Chien-Fu Hung, Richard B S Roden
Published 2015-10-01

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

by Kihyuck Kwak, Rosie Jiang, Subhashini Jagu, Joshua W Wang, Chenguang Wang, Neil D Christensen, Richard B S Roden
Published 2013-01-01

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.

by Joshua W Wang, Subhashini Jagu, Chenguang Wang, Henry C Kitchener, Sai Daayana, Peter L Stern, Susana Pang, Patricia M Day, Warner K Huh, Richard B S Roden
Published 2014-01-01

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.

by Shiwen Peng, Joshua W Wang, Balasubramanyam Karanam, Chenguang Wang, Warner K Huh, Ronald D Alvarez, Sara I Pai, Chien-fu Hung, T-C Wu, Richard B S Roden
Published 2015-01-01